Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
G. A. Anwar, S. Bourke, G. Afolabi, C. Ward, P. Middleton, N. Wong, L. Murray, R. Rutherford (North Shields, Newcastle upon Tyne, United Kingdom). Longitudinal decline in FEV1 in an adult non-cystic fibrosis bronchiectasis cohort. Eur Respir J 2007; 30: Suppl. 51, 3183

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Lung function decline in a modern cystic fibrosis cohort Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007 Non-cystic fibrosis bronchiectasis in children Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Revisiting FEV1 in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 127s Year: 2001 Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Year: 2015 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Exercise capacity can predict exacerbations and hospitalizations in a 1-year follow up in non-cystic fibrosis bronchiectasis adults Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Postural changes in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009 Postural changes in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2012 - New insights in the physical assessment and therapy of respiratory patients Year: 2012 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Lung function decline in patients with bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015